Terms: = Cervical cancer AND uPA AND Treatment
16 results:
1. Epidermal growth factor receptor regulates fibrinolytic pathway elements in cervical cancer: functional and prognostic implications.
Gomes FG; Almeida VH; Martins-Cardoso K; Martins-Dinis MMDC; Rondon AMR; Melo AC; Tilli TM; Monteiro RQ
Braz J Med Biol Res; 2021; 54(6):e10754. PubMed ID: 33886813
[TBL] [Abstract] [Full Text] [Related]
2.
Liao CL; Chu YL; Lin HY; Chen CY; Hsu MJ; Liu KC; Lai KC; Huang AC; Chung JG
Anticancer Res; 2018 Jul; 38(7):3989-3997. PubMed ID: 29970522
[TBL] [Abstract] [Full Text] [Related]
3. Urokinase-plasminogen activator protects periodontal ligament fibroblast from oxidative induced-apoptosis and DNA damage.
Ahmad Akhoundi MS; Rokn A; Bagheri R; Momeni N; Hodjat M
J Periodontal Res; 2018 Oct; 53(5):861-869. PubMed ID: 29920670
[TBL] [Abstract] [Full Text] [Related]
4. Effect of a synthetic inhibitor of urokinase plasminogen activator on the migration and invasion of human cervical cancer cells in vitro.
Wang X; Jiang Z; An J; Mao X; Lin F; Sun P
Mol Med Rep; 2018 Mar; 17(3):4273-4280. PubMed ID: 29328476
[TBL] [Abstract] [Full Text] [Related]
5. Downregulation of Extracellular Matrix Metalloproteinase Inducer by scFv-M6-1B9 Intrabody Suppresses cervical cancer Invasion Through Inhibition of Urokinase-Type Plasminogen Activator.
Panich T; Tragoolpua K; Pata S; Tayapiwatana C; Intasai N
Cancer Biother Radiopharm; 2017 Feb; 32(1):1-8. PubMed ID: 28118037
[TBL] [Abstract] [Full Text] [Related]
6. Kallistatin Suppresses Cell Proliferation and Invasion and Promotes Apoptosis in cervical cancer Through Blocking NF-κB Signaling.
Wang T; Shi F; Wang J; Liu Z; Su J
Oncol Res; 2017 May; 25(5):809-817. PubMed ID: 27983915
[TBL] [Abstract] [Full Text] [Related]
7. Downregulation of FoxM1 inhibits proliferation, invasion and angiogenesis of HeLa cells in vitro and in vivo.
Chen H; Zou Y; Yang H; Wang J; Pan H
Int J Oncol; 2014 Dec; 45(6):2355-64. PubMed ID: 25201015
[TBL] [Abstract] [Full Text] [Related]
8. Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in human female cancer cell lines.
Roomi MW; Kalinovsky T; Rath M; Niedzwiecki A
Oncol Rep; 2012 Sep; 28(3):768-76. PubMed ID: 22736175
[TBL] [Abstract] [Full Text] [Related]
9. Is the circulating urokinase plasminogen activator upregulated by the circulating p105 fraction of the HER-2/neu proto-oncogene in patients with cervical cancer?
Contreras DN; Cobos E; Lox C
Clin Appl Thromb Hemost; 2004 Jul; 10(3):271-6. PubMed ID: 15247985
[TBL] [Abstract] [Full Text] [Related]
10. Inhibition of the invasion capacity of carcinoma cells by WX-UK1, a novel synthetic inhibitor of the urokinase-type plasminogen activator system.
Ertongur S; Lang S; Mack B; Wosikowski K; Muehlenweg B; Gires O
Int J Cancer; 2004 Jul; 110(6):815-24. PubMed ID: 15170662
[TBL] [Abstract] [Full Text] [Related]
11. Expression of active plasminogen activator inhibitor-1 reduces cell migration and invasion in breast and gynecological cancer cells.
Whitley BR; Palmieri D; Twerdi CD; Church FC
Exp Cell Res; 2004 Jun; 296(2):151-62. PubMed ID: 15149846
[TBL] [Abstract] [Full Text] [Related]
12. Minimal residual disease in breast cancer and gynecological malignancies: phenotype and clinical relevance.
Roggel F; Hocke S; Lindemann K; Sinz S; Welk A; Bosl M; Pabst M; Nusser N; Braun S; Schmitt M; Harbeck N
Recent Results Cancer Res; 2003; 162():89-100. PubMed ID: 12790324
[TBL] [Abstract] [Full Text] [Related]
13. Effects of EGF and TGF-alpha on invasion and proteinase expression of uterine cervical adenocarcinoma OMC-4 cells.
Ueda M; Fujii H; Yoshizawa K; Terai Y; Kumagai K; Ueki K; Ueki M
Invasion Metastasis; 1998-1999; 18(4):176-83. PubMed ID: 10640903
[TBL] [Abstract] [Full Text] [Related]
14. [Genistein suppresses growth stimulatory effect of growth factors in HCE 16/3 cells].
Zheng J
Zhonghua Zhong Liu Za Zhi; 1997 Mar; 19(2):118-22. PubMed ID: 10743075
[TBL] [Abstract] [Full Text] [Related]
15. Keratinocyte growth factor enhances urokinase-type plasminogen activator activity in HPV16 DNA-immortalized human uterine exocervical epithelial cells.
Zheng J; Siren V; Vaheri A
Eur J Cell Biol; 1996 Feb; 69(2):128-34. PubMed ID: 8907612
[TBL] [Abstract] [Full Text] [Related]
16. [Study on the plasma plasminogen activators in patients with malignant gynecologic tumors].
Shimada H; Ikeuchi M; Suwa M; Michimoto T; Ono Y; Tanada S; Himeno K; Hoshino T; Takashima E
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1353-9. PubMed ID: 2511260
[TBL] [Abstract] [Full Text] [Related]
